Saturday, November 28, 2020

Teva Pharmaceutical (TEVA) revised its financial forecast after low third-quarter sales

- Advertisement -
- Advertisement -

Teva Pharmaceutical (TEVA) announced its financial results on Thursday reporting low third-quarter sales and the company reduce its full-year revenue figures.

Teva reported 58 cents per share income for the quarter ended September 30, 2020, which is in line with the analyst’s estimates. The earing remains flat over the year. The company sales declined by 2.8% and the company earned $3.98 billion in sales, which is way behind than the $4.06 billion estimates. After the announcement, Teva stock floored 6.5% to 8.61.

The sales of generic products climbed 2% to $928 million in North America, but generic product sales declined in Europe and international markets1% and 10% respectively year over year.

The revenue from the sales of Copaxone declined in all three geographies and it was declined most in the North America where it dipped to 13% to $236 million which is still $26 million higher than the analyst’s forecast.

But that beat forecasts by $26 million, SVB Leerink analyst Ami Fadia said in a note to clients. She retained her market perform rating on Teva stock.

Copaxone is facing tough competition due to generic copies but Teva said that Copaxone has ‘stabilized’ in the U.S.

Teva revised its sales figure for the year. Now Teva is looking to earn16.5 billion to $16.8 billion in sales, which is $150 million lower than previous guidance at the midpoint. Also, the earning per share has been revised and Teva expecting $2.40-$2.55 earnings per share whereas analysts’ estimates are $16.65 billion in sales and $2.48 per share.

- Advertisement -

Latest news

Big Tech playersare coming under scrutiny bythe new U.K. antitrust unit

The U.K government said its new division would be working to resolve ongoing questions about power accumulation by a limited group of tech giants. The Department...
- Advertisement -

Goldman Sachs (GS) using drone technology to seal the deals during the pandemic

The world’s top mergers advisor, Goldman Sachs (GS) is now using drone technology to give its clients a bird’s-eye view of the companies they...

Fanhua Inc (FANH) announced a quarterly cash dividend and One America News Network (OANN) got one-week suspension after posting fake COVID-19 cure

Fanhua Inc (FANH), a leading independent financial services provider in China today announced its quarterly dividend of $0.0125 per ordinary share or $0.25 per...

Apple, Inc.(AAPL) extends its App store fee Wavier for Digital classes

Apple announced a 30% commission fee waiver extension for the companies that offer digital classes or virtual events through iPhone apps. Those companies would...

Related news

Big Tech playersare coming under scrutiny bythe new U.K. antitrust unit

The U.K government said its new division would be working to resolve ongoing questions about power accumulation by a limited group of tech giants. The Department...

Goldman Sachs (GS) using drone technology to seal the deals during the pandemic

The world’s top mergers advisor, Goldman Sachs (GS) is now using drone technology to give its clients a bird’s-eye view of the companies they...

Fanhua Inc (FANH) announced a quarterly cash dividend and One America News Network (OANN) got one-week suspension after posting fake COVID-19 cure

Fanhua Inc (FANH), a leading independent financial services provider in China today announced its quarterly dividend of $0.0125 per ordinary share or $0.25 per...

Apple, Inc.(AAPL) extends its App store fee Wavier for Digital classes

Apple announced a 30% commission fee waiver extension for the companies that offer digital classes or virtual events through iPhone apps. Those companies would...
- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here